Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. It operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. Additionally, the devices assist people with a variety of upper extremity disabilities and enable industrial employees to perform challenging repetitive tasks for extended periods.
äŒæ¥ã³ãŒãEKSO
äŒç€ŸåEkso Bionics Holdings Inc
äžå Žæ¥Apr 10, 2013
æé«çµå¶è²¬ä»»è
ãCEOãDavis (Scott G)
åŸæ¥å¡æ°61
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Apr 10
æ¬ç€Ÿæåšå°101 Glacier Point
éœåžSAN RAFAEL
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·94901
é»è©±çªå·15109841761
ãŠã§ããµã€ãhttps://eksobionics.com/
äŒæ¥ã³ãŒãEKSO
äžå Žæ¥Apr 10, 2013
æé«çµå¶è²¬ä»»è
ãCEOãDavis (Scott G)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã